Nephrocare Health Services Ltd (NEPHROPLUS) Stock Price & News

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	2.37B	2.60B	2.66B	2.89B
Cost of goods sold	1.48B	1.52B	1.85B	1.62B
Cost of revenue	1.48B	1.52B	1.85B	1.62B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	56.22M	-	251.70M	-
Operating expense	536.82M	684.30M	503.40M	799.44M
Total operating expenses	2.02B	2.21B	2.35B	2.42B
Operating income	349.68M	390.04M	304.70M	468.02M
Other non operating income	-3.46M	33.16M	-119.95M	-
EBT including unusual items	139.46M	363.60M	332.19M	410.30M
EBT excluding unusual items	135.88M	363.60M	266.31M	410.30M
Income tax expense	68.32M	41.20M	28.49M	90.56M
Effective tax rate	48.99%	11.33%	8.58%	22.07%
Other operating expenses	271.69M	465.69M	5.03M	554.04M
Net income	71.14M	322.40M	303.70M	319.74M
Net profit margin	3.00%	12.41%	11.43%	11.06%
Earnings per share	-	-	-	3.11
Interest and investment income	-	-	97.07M	-
Interest expense	-251.32M	-59.60M	-9.04M	-22.06M
Net interest expenses	-227.08M	-59.60M	88.03M	-22.06M
Depreciation and amortization charges	208.90M	218.61M	246.63M	245.40M
EBITDA	521.27M	561.64M	492.71M	656.03M
Gain or loss from assets sale	1.12M	-	-	-

Finance